The use of Eudragit® RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 72, Issue 3, 2009, Pages 509-520

  Lopedota, Angela ^a   Trapani, Adriana ^a   Cutrignelli, Annalisa ^a   Chiarantini, Laura ^b   Pantucci, Elena ^b   Curci, Rosa ^b   Manuali, Elisabetta ^c   Trapani, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL UMBRIA E DELLE MARCHE   (Italy)

Author keywords

Cyclodextrins; Eudragit RS 100; GSH; Nanoparticles; Transmucosal administration

Indexed keywords

CYCLODEXTRIN; EUDRAGIT RS; GLUTATHIONE; NANOPARTICLE; SOLVENT; ACRYLIC ACID RESIN;

ANIMAL CELL; ARTICLE; CELL LINE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DIFFUSION; DRUG ABSORPTION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; EMULSION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOUSE; MUCOADHESION; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; SOLID STATE; SURFACE CHARGE; THERMAL ANALYSIS; X RAY DIFFRACTION; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; FROG; HORSE; METABOLISM; MUCOSA; SWINE;

ACRYLIC RESINS; ANIMALS; CELL LINE; CYCLODEXTRINS; GLUTATHIONE; HORSES; HUMANS; MICE; MUCOUS MEMBRANE; NANOPARTICLES; RANA ESCULENTA; SWINE; X-RAY DIFFRACTION;

EID: 67449164351     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.02.013     Document Type: Article

References (38)

1. Banga A.K. Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems. second ed. (2006), CRC Press Taylor and Francis, London, UK
2. Florence A.T., and Attwood D. Physicochemical Principles of Pharmacy. fourth ed. (2006), Pharmaceutical Press, London, UK pp. 431-461
3. Prego C., Garcia M., Torres D., and Alonso M.J. Transmucosal macromolecular drug delivery. J. Control. Release 101 (2005) 151-162
4. Csaba N., Garcia-Fuentes M., and Alonso M.J. The performance of nanocarriers for transmucosal drug delivery. Expert Opin. Drug Deliv. 3 (2006) 463-478
5. Alleman E., Leroux J.C., and Gurny R. Polymeric nano- and micro-particles for the oral delivery of peptides and peptidomimetics. Adv. Drug Deliv. Rev. 34 (1998) 171-189
6. Jenner P. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol. Biol. 44 (1996) 57-64
7. Samuni A.M., Chuang E.Y., Krishna M.C., Stein W., DeGraff W., Russo A., and Mitchell J.B. Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: Chemoprevention strategies with antioxidants. Proc. Natl. Acad. Sci. USA 100 (2003) 5390-5395
8. Flagg E.W., Coates R.J., Jones D.P., Byers T.E., Greenberg R.S., Gridley G., McLaughlin J.K., Blot W.J., Haber M., and Preston-Martin S. Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am. J. Epidemiol. 139 (1994) 453-465
9. Mihm S., Ennen J., Pessara U., Kurth V., and Droge W. Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives. AIDS 5 (1991) 497-503
10. Carter-Dawsona L., Shen F., Harwerth R.S., Crawford M.L.J., Smith E.L., and Whitetree A. Glutathione content is altered in Müller cells of monkey eyes with experimental glaucoma. Neurosci. Lett. 364 (2004) 7-10
11. Langoth N., Bernkop-Schnurch A., and Kurka P. The inhibitory effect of glutathione on buccal enzymatic degradation of therapeutic peptides (leu-enkephalin, luteinizing hormone-releasing hormone and pituitary adenylate cyclase activating peptide). J. Drug Del. Sci. Tech. 15 (2005) 435-438
12. Pignatello R., Bucolo C., Ferrara P., Maltese A., Puleo A., and Puglisi G. Eudragit RS 100 nanosuspension for the ophthalmic controlled delivery of ibuprofen. Eur. J. Pharm. Sci. 16 (2002) 53-61
13. Ubrich N., Schmidt C., Bodmeier R., Hoffman M., and Maincent P. Oral evaluation in rabbits of cyclosporine-loaded Eudragit RS or RL nanoparticles. Int. J. Pharm. 288 (2005) 69-175
14. Vaquette C., Babak V.G., Baros F., Boulanouar O., Dumas D., Fievet P., Kildeeva N.R., Maincent P., and Wang X. Zeta-potential and morphology of electrospun nano- and microfibers from biopolymers and their blends used as scaffolds in tissue engineering. Mendeleev Commun. 18 (2008) 38-41
15. Boudad H., Legrand P., Lebas G., Cheron M., Duchêne D., and Ponchel G. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. Int. J. Pharm. 218 (2001) 113-124
16. Haeberlin B., Gengenbacher T., Meinzer A., and Fricker G. Cyclodextrins-useful excipients for oral peptide administration?. Int. J. Pharm. 137 (1996) 103-110
17. Irie T., and Uekama K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 36 (1999) 101-123
18. Kafedjiiski K., Werle M., Foger F., and Bernkop-Schnürch A. Synthesis and in vitro characterization of a novel poly(acrylic acid)-glutathione conjugate. J. Drug Del. Sci. Tech. 15 (2005) 411-417
19. Townsend D.M., Tew K.D., and Tapiero H. The importance of glutathione in human disease. Biomed. Pharmacother. 57 (2003) 145-155
20. Trapani A., Laquintana V., Denora N., Lopedota A., Cutrignelli A., Franco M., Trapani G., and Liso G. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Eur. J. Pharm. Sci. 30 (2007) 64-74
21. Lopedota A., Trapani A., Cutrignelli A., Laquintana V., Denora N., Franco M., Trapani G., and Liso G. Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione. J. Incl. Phenom. Macrocycl. Chem. 57 (2007) 425-432
22. Gate L., Vauthier C., Couvreur P., Tew K.D., and Tapiero H. Glutathione-loaded poly(isobutylcyanoacrylate) nanoparticles and liposomes: comparative effects in murine erythroleukemia and macrophage-like cells. S.T.P. Pharma Sci. 11 (2001) 355-361
23. Kawashima Y., Niwa T., Handa T., Takeuchi H., Iwamoto T., and Itho K. Preparation of controlled-release microspheres of ibuprofen with acrylic polymer by a novel quasi-emulsion solvent diffusion method. J. Pharm. Sci. 78 (1989) 68-72
24. Galindo-Rodriguez S., Allemann E., Fessi H., and Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm. Res. 21 (2004) 1428-1439
25. Da Silveira A.M., Ponchel G., Puisieux F., and Duchene D. Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm. Res. 15 (1998) 1051-1055
26. Garcia-Fuentes M., Trapani A., and Alonso M.J. Protection of the peptide glutathione by complex formation with alpha-cyclodextrin: NMR spectroscopic analysis and stability study. Eur. J. Pharm. Biopharm. 64 (2006) 146-153
27. Donini C., Robinson D.N., Colombo P., Giordano F., and Peppas N.A. Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int. J. Pharm. 245 (2002) 83-91
28. Rossi S., Ferrari F., Bonferoni M.C., and Caramella C. Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements. Eur. J. Pharm. Sci. 10 (2000) 251-257
29. Lamprecht A., Koenig P., Ulbrich N., Maincent P., and Neumann D. Low molecular weight heparin nanoparticles: mucoadhesion and behavior in Caco-2 cells. Nanotechnology 17 (2006) 3673-3680
30. Camera E., and Picardo M. Analytical methods to investigate glutathione and related compounds in biological and pathological processes. J. Chromatogr. B 781 (2002) 81-206
31. Morgan D.M., Larvin V.L., and Pearson J.L. Biochemical characterization of polycation-induced cytotoxicity to human vascular endothelial cells. J. Cell. Sci. 94 (1989) 553-559
32. Maas-Szabowski N., Starker A., and Fusenig N.E. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-α. J. Cell. Sci. 116 (2003) 2937-2948
33. Ahsan F., Rivas I.P., Khan M.A., and Torres Suarez A.I. Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages. J. Control. Release 79 (2002) 29-40
34. Trapani G., Franco M., Trapani A., Lopedota A., Latrofa A., Gallucci E., Micelli S., and Liso G. Frog intestinal sac: a new in vitro method for the assessment of intestinal permeability. J. Pharm. Sci. 93 (2004) 2909-2919
35. Franco M., Lopedota A., Trapani A., Cutrignelli A., Meleleo D., Micelli S., and Trapani G. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: application to carrier transported drugs. Int. J. Pharm. 352 (2008) 182-188
36. Shipper N.G., Olsson S., Hoogstrate J.A., deBoer A.G., Varum K.M., and Artusson P. Chitosans as absorption enhancers for poorly absorbable drugs: 2. Mechanism of absorption enhancement. Pharm. Res. 14 (1997) 923-929
37. Svobodová A., Zdarilová A., Walterová D., and Vostálová J. Flavonolignans from Silybum marianum moderate UVA-induced oxidative damage to HaCaT keratinocytes. J. Dermatol. Sci. 48 (2007) 213-224
38. Zhu M., and Bowden G.T. Molecular mechanism(s) for UV-B irradiation-induced glutathione depletion in cultured human keratinocytes. Photochem. Photobiol. 80 (2004) 191-196